Acelity Acquires Crawford Healthcare
London – June 28, 2018 – Cooley advised Acelity, a global leader in wound care, on the acquisition of Crawford Healthcare. Justin Stock, Cooley’s UK managing partner, led the team advising Acelity.
Crawford Healthcare is a recognized leader in developing and commercializing innovative treatments for the care and repair of skin. Through the combination, Acelity has expanded its portfolio of advanced wound dressings, strengthening its position as global leader and creating the world’s most expansive wound care portfolio.
Acelity is headquartered in San Antonio, Texas, and employs nearly 5,000 people worldwide. Its subsidiary, KCI, is the most trusted brand in advanced wound care with products available in more than 90 countries.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.